June 24, 2026
An integrative, physician-designed protocol for the most common autoimmune disease in Indian women — addressing thyroid antibodies, persistent symptoms despite ‘normal’ TSH, and the upstream drivers conventional endocrinology often cannot reach.
What it targets: The autoimmune process driving thyroid antibody production (TPO and thyroglobulin), persistent symptoms despite ‘TSH in range’, and the upstream drivers — selenium status, gut, gluten, immune balance, and hormonal context.
Who it’s for: Adults with diagnosed Hashimoto’s or autoimmune hypothyroidism (elevated TPO and/or thyroglobulin antibodies), under endocrinology care, seeking integrative support.
How it works: Physician-supervised combination of evidence-based thyroid hormone optimisation, selenium and targeted micronutrient repletion, gut-gluten-immune-hormonal upstream work, plus the lifestyle layer that influences autoimmune disease activity.
What to expect: Energy, brain fog, cold intolerance, and persistent fatigue often shift in early and building phases. Thyroid antibodies may decline meaningfully over building and sustained phases. Outcomes vary significantly. ALIV does not guarantee antibody reduction, levothyroxine reduction, or remission.
Hashimoto’s thyroiditis is the most common autoimmune disease in Indian women — and one of the most under-recognised. Many of our clients arrive specifically researching Hashimoto’s treatment, hypothyroidism treatment, TPO antibodies high, TSH normal but still tired, or functional medicine thyroid care in India — and want an integrative approach alongside their endocrinologist. The landmark 2013 Indian eight-city epidemiological study found hypothyroidism prevalence around 11% across major Indian cities, with women predominantly affected. Many women carry elevated TPO antibodies for years before TSH ever drifts up.
If you have Hashimoto’s, you know the pathway: a TSH that drifted up, a positive TPO antibody, levothyroxine started. For many clients this is enough. For others, it is the start of a longer story: TSH in range, but ongoing fatigue, brain fog, cold intolerance, weight resistance, mood symptoms, and antibodies that remain high. Conventional endocrinology often does not have time for the upstream layer; this protocol does.
This protocol was built for you if:
Important: This protocol is integrative, not alternative. ALIV does not support stopping or reducing levothyroxine without endocrinology supervision. Your endocrinologist remains the primary clinician.
Hashimoto’s is a chronic autoimmune disease in which the immune system progressively destroys thyroid tissue through antibody-mediated processes. Hormone replacement corrects the resulting hypothyroidism. Integrative care addresses the autoimmune process itself and its upstream drivers.
Levothyroxine (T4) is standard of care. But ‘TSH in range’ doesn’t guarantee symptom resolution — some clients convert T4 to active T3 poorly. Free T3, reverse T3, and the T3:RT3 ratio matter clinically. Where this picture is identified, selective T3 augmentation has evidence. Always coordinated with your endocrinologist; ALIV does not adjust thyroid medication independently.
Selenium has the strongest nutritional evidence in Hashimoto’s. A 2024 meta-analysis of randomized trials demonstrated selenium reduced TSH and TPO antibody levels, most consistently in clients not on thyroid hormone replacement. Beyond selenium, this layer addresses commonly deficient nutrients: Vitamin D (deficient in many Indian adults), Zinc (thyroid hormone synthesis cofactor), Vitamin B12 (commonly deficient in Indian vegetarians), and Iron (essential for thyroid peroxidase). Repletion targeted to your assessment.
Hashimoto’s clusters with celiac disease, gluten sensitivity, and other autoimmune conditions. The gut-thyroid-immune axis is one of the most clinically significant relationships in autoimmune medicine. Celiac is meaningfully more common in Hashimoto’s; screening is appropriate. Confirmed celiac requires strict gluten-free; for the rest, structured trial elimination under physician guidance is the right approach. In selected cases, Thymosin Alpha-1 supports immune balance. Hashimoto’s also intersects with perimenopause: oestrogen flux can trigger flares, which is why the Perimenopause Protocol coordinates where relevant.
Your ALIV physician runs a workup beyond standard endocrinology surveillance: full thyroid panel (TSH, Free T4, Free T3, Reverse T3, TPO and thyroglobulin antibodies), micronutrient panel (Vitamin D, B12, iron, zinc), inflammatory markers, celiac screen where indicated, plus review of medication, lifestyle, and hormonal context. Protocol coordinated with your endocrinologist. Initiated only when hypothyroidism is stable.
Hashimoto’s is a chronic disease, and integrative care produces gradual, progressive improvement rather than rapid transformation. Symptom improvement typically precedes antibody change.
Phase | What You May Notice |
Early phase | Energy, brain fog, cold intolerance often shift first. Sleep and mood may improve. |
Building phase | Symptom burden continues reducing. Antibody levels may decline. Endocrinologist may identify medication-titration opportunities. |
Sustained phase | Quality-of-life gains consolidate. Protocol shifts toward maintenance. |
Individual outcomes vary significantly. ALIV does not guarantee antibody reduction, levothyroxine dose reduction, or symptom remission.
Before starting, your ALIV team runs the diagnostic assessment, reviews your endocrinology management, and — with your permission — coordinates with your endocrinologist. Contraindications detailed in the FAQ below.
In Hashimoto’s, daily inputs are clinical inputs — diet, sleep, stress, and movement influence autoimmune activity, antibody trajectory, and how you feel.
Nutrition, sleep, stress, movement: adequate protein for thyroid hormone synthesis, anti-inflammatory dietary patterns, and — critically — avoidance of excessive iodine (kelp, iodine drops, certain wellness products) which can paradoxically worsen Hashimoto’s. Sleep disruption worsens immune dysregulation; the Sleep Protocol coordinates where indicated. Stress worsens autoimmune activity via cortisol effects on immune regulation and gut. Movement is essential, but pacing matters — excessive intensity during fatigue backfires.
Underrecognised triggers: smoking worsens autoimmune thyroid disease. Excessive alcohol adds inflammatory load. Untreated infections — chronic dental, gut, EBV reactivation — drive immune activation in flares.
Can Hashimoto’s be reversed or cured?
Established Hashimoto’s cannot be fully cured — the autoimmune process is durable and most clients require lifelong thyroid hormone replacement. Achievable for many: meaningful TPO antibody reduction, symptom improvement despite normal TSH, optimisation of T3/T4 conversion, and in some early-diagnosis cases lower levothyroxine requirements (specialist-directed). True reversal in early autoimmunity (positive antibodies before clinical hypothyroidism) has stronger trajectory-modification potential. Stopping levothyroxine to chase ‘cure’ usually causes harm.
Will I be able to stop levothyroxine?
In most clients with established Hashimoto’s, no — levothyroxine is often lifelong because the autoimmune process has caused thyroid tissue loss. In early-diagnosis clients with intact function, dose reduction may be possible — always with your endocrinologist.
Why do I still feel terrible despite normal TSH?
One of the most common Hashimoto’s presentations. ‘TSH in range’ doesn’t guarantee optimal thyroid status. Free T3, RT3, T3:RT3 ratio, ongoing autoimmune activity, and micronutrient deficiencies all contribute. Layer 1 and the full workup address this.
Should I go gluten-free?
If you have confirmed celiac disease, yes — Hashimoto’s clients should be screened. Without confirmed celiac, evidence for blanket gluten elimination is mixed. A structured 3-month trial elimination can be considered under physician guidance.
What about T3 medication or natural desiccated thyroid?
Selective T3 augmentation has evidence for symptomatic clients who don’t respond fully to T4 alone, always coordinated with your endocrinologist. Natural desiccated thyroid has variable T4:T3 ratios; modern combination therapy with controlled dosing is often preferred.
Will my TPO antibodies actually go down?
Sometimes yes, sometimes only modestly. Selenium has documented effect on TPO reduction across meta-analyses; addressing gut, nutritional, and lifestyle drivers can support further reduction. ALIV does not guarantee specific antibody outcomes.
I’m trying to conceive — does Hashimoto’s affect this?
Yes, meaningfully. Women with Hashimoto’s show substantially elevated infertility rates in cohorts — around 47% — and elevated TPO antibodies independently affect fertility and pregnancy outcomes. Pre-conception thyroid optimisation matters; coordination with your reproductive endocrinologist is essential.
Who should NOT do this protocol?
Severely uncontrolled hypothyroidism requiring acute endocrinology management; thyroid storm history without specialist clearance; pregnancy without endocrinology coordination; clients seeking to bypass specialist care.
Hashimoto’s affects more Indian women than any other autoimmune disease — and is most often dismissed with ‘your TSH is normal’. It deserves better than that.
To find out if the Hashimoto’s Thyroiditis Protocol is right for you, speak with our medical team:
Or book a consultation through alivtherapy.in.
1. Huwiler VV, Maissen-Abgottspon S, Stanga Z, et al. Selenium supplementation in patients with Hashimoto thyroiditis: a systematic review and meta-analysis of randomized clinical trials. Thyroid. 2024;34(3):295-313. PMID: 38243784
2. Unnikrishnan AG, Kalra S, Sahay RK, et al. Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17(4):647-652. PMID: 23961480
3. Pica F, Chimenti MS, Gaziano R, et al. Serum thymosin α1 levels in patients with chronic inflammatory autoimmune diseases. Clin Exp Immunol. 2016;186(1):39-45. DOI: 10.1111/cei.12833
4. Dinetz E, Lee E. Comprehensive review of the safety and efficacy of Thymosin Alpha 1 in human clinical trials. Altern Ther Health Med. 2024;30(1):6-12. PMID: 38308608
5. Misra DP, Sharma A, Dharmanand BG, Chandrashekara S. The epidemiology of rheumatic diseases in India. Indian J Rheumatol. 2024;19(2_suppl):S147-S160. DOI: 10.1177/09733698241229779
Disclaimer
The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including Hashimoto’s thyroiditis or autoimmune hypothyroidism. This protocol is integrative supportive care provided alongside — not as a replacement for — specialist endocrinology management. Outcomes vary significantly; ALIV does not guarantee antibody reduction, levothyroxine dose reduction, symptom remission, or any specific clinical outcome. Levothyroxine, T3 augmentation, and any thyroid medication changes must be coordinated with your endocrinologist. Selenium dosing requires physician guidance — excessive selenium is harmful. Iodine supplementation in Hashimoto’s can worsen the condition and must be avoided unless physician-directed. Thymosin Alpha-1 is FDA-approved for specific indications and used off-label in integrative autoimmune support. Please consult a qualified healthcare professional before starting any therapy programme.